After GRg3 treatment, the expression of apoptosis-related genes, which target SOX2 and the PI3K/AKT/mTOR signaling pathway, was upregulated in gastric cancer cells, cell migration was significantly inhibited, GRg3 alleviated the drug resistance of gastric cancer cells, and sensitivity to cisplatin was enhanced (13). Here, MTOR is linked to gastric cancer.